Platelet-rich plasma in the treatment of scleroatrophic lichen of the genitals
https://doi.org/10.30629/0023-2149-2022-100-11-12-540-545
Abstract
The article provides comparative analysis of the current studies on the use of platelet-rich plasma (PRP) for the treatment of lichen sclerosus. The analysis includes 9 articles on efficiency of PRP in patients with genital lichen sclerosus. The article includes a listing of research and methods for evaluating the effect of therapy protocols. Most of the studies have shown a good therapeutic effect of the disease treatment with platelet-rich plasma. PRP may be used to quickly resolve subjective symptoms and reduce inflammation, as well as to treat synechia and cicatricial conditions. However, a problem concerning the mechanism of PRP, combined therapy with PRP, and topical steroids, has not been studied yet. It is necessary to conduct additional studies that will help to determine the number of procedures, and the interval between them. It is also necessary to develop criteria for evaluating the therapy effect, which includes histological examination.
About the Authors
O. V. Parygina
Lahta Clinic; Federal State Budgetary Institution “Almazov National Medical Research Centre”, Institute of Medical Education
Russian Federation
Russian Federation
Parygina Olga V.
197183, St. Petersburg
197341, St. Petersburg
M. V. Oganesyan
St. Petersburg State University
Russian Federation
Russian Federation
Oganesyan Marianna V.
199034, St. Petersburg
N. V. Shin
St. Petersburg State University
Russian Federation
Russian Federation
Shin Natalia V.
199034, St. Petersburg
I. O. Smirnova
St. Petersburg State University; City Skin and Venereological Dispensary
Russian Federation
Russian Federation
Smirnova Irina O.
199034, St. Petersburg
192102, St. Petersburg
References
1. Al-Niaimi F., Lyon C. Peristomal lichen sclerosus: The role of occlusion and urine exposure? The British journal of dermatology. 2013;168:643–646. DOI: 10.1111/bjd.12014
2. Pappas-Taffer L.K. Lichen sclerosis. Medscape. 2017. [Electronic resource]. URL: https://emedicine.medscape.com/article/1123316-overview
3. Tran D.A., Tan X., Macri C.J., Goldstein A.T., Fu S.W. Lichen Sclerosus: An autoimmunopathogenic and genomic enigma with emerging genetic and immune targets. International Journal of Biological Sciences. 2019;15(7):1429–1439. DOI: 10.7150/ijbs.34613
4. Potekaev N.S., Plieva L.R., Tepliuk N.P., Sergeev Iu.Iu. A polymorphic variant of lichen sclerosus. Klinicheskaya Dermatologiya i Venerologiya. 2014;12(2):3540. (In Russian).
5. Powell J.J., Wojnarowska F. Lichen sclerosus. The Lancet. 1999;353(9166):1777–1783. DOI: 10.1016/s0140-6736(98)08228-2
6. Bleeker M.C., Visser P.J., Overbeek L.I., Beurden M., Berkhof J. Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer epidemiology, biomarkers & prevention. 2016;25(8):1224–1230. DOI: 10.1158/1055-9965.EPI-16-0019
7. Chi C. C., Kirtschig G., Baldo M., Lewis F., Wang S.-H., Wojnarowska F. Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus. Journal of the American Academy of Dermatology. 2016;67(2):305–312. DOI: 10.1016/j.jaad.2012.02.044
8. Kirtschig G., Becker K., Günthert A., Jasaitiene D., Cooper S., Chi C.-C., Kreuter A., Rall K.-K., Aberer W., Riechardt S., Casabona F., Powell J., Brackenbury F., Erdmann R., Lazzeri M., Barbagli G., Wojnarowska F. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. Journal of the European Academy of Dermatology and Venereology: JEADV. 2015;29(10):1–43. DOI: 10.1111/jdv.13136
9. Virgili A., Corazza M., Minghetti S., Borghi A. Growing evidence for topical mometasone fuoroate in the treatment of Vulvar Lichen Sclerosus. Maturitas. 2015;80(1):113–115. DOI: 10.1016/j.maturitas.2014.09.005
10. Borghi A., Corazza M., Minghetti S., Virgili A. Topical tretinoin in the treatment of vulvar lichen sclerosus: an advisable option? European journal of dermatology: EJD. 2015;25(5):404–409. DOI: 10.1684/ejd.2015.2595
11. Borghi A., Corazza M., Minghetti S., Bianchini E., Virgili A. Dermoscopic features of vulvar lichen sclerosus in the setting of a prospective cohort of patients: new observations. Dermatology: international journal for clinical and investigative dermatology. 2016;232(1):71–77. DOI: 10.1159/000439198
12. Margesson L.J. Overview of treatment of vulvovaginal disease. Skin Therapy Letter. 2011;16(3):5–7. [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/21611679/
13. Johnson E., Groben P., Eanes A., Iyer P., Ugoeke J., Zolnoun D. Vulvar skin atrophy induced by topical glucocorticoids. Journal of Midwifery and Women’s Health. 2012;57(3):296–299. DOI: 10.1111/j.1542-2011.2012.00189.x
14. Casabona F., Priano V., Vallerino V., Casabona F., Santi P., Santorini G., Baldelli I. Autologous Platelet-Rich Plasma (PRP) in Chronic Penile Lichen Sclerosus: The Impact on Tissue Repair and Patient Quality of Life. International Urology and Nephrology. 2017;49(4):573–580. DOI: 10.1007/s11255-017-1523-0
15. Marx R.E. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dentistry. 2001;10(4):225–228. DOI: 10.1097/00008505-200110000-00002
16. Lubkowska A., Dolegowska B., Banfi G. Growth factor content in PRP and their applicability in medicine. Journal of Biological Regulators and Homeostatic Agents. 2012;26(2):3–22. [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/23648195/
17. Mehta S., Watson J.T. Platelet rich concentrate: basic science and current clinical applications. Journal of Orthopaedi Trauma. 2008;22(6):432–438. DOI: 10.1097/BOT.0b013e31817e793f
18. Suthar M., Gupta S., Bukhari S., Ponemone V. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. Journal of Biomedical Science. 2017;24(16):1–10. DOI: 10.1186/s12929-017-0324-1
19. Hersant B., SidAhmed-Mezi M., Picard F., Hermeziu O., Rodriguez A.-M., Ezzedine K., Meningaud J.P. Efficacy of Autologous Platelet Concentrates as Adjuvant Therapy to Surgical Excision in the Treatment of Keloid Scars Refractory to Conventional Treatments: A Pilot Prospective Study. Annals of Plastic Surgery. 2018;81(2):170–175. DOI: 10.1097/SAP.0000000000001448
20. Casabona F., Priano V., Vallerino V., Cogliandro A., Lavagnino G. New surgical approach to lichen sclerosus of the vulva: the role of adipose-derived mesenchymal cells and platelet-rich plasma in tissue regeneration. Plastic and Reconstructive Surgery. 2010;126(4):210–211. DOI: 10.1097/PRS.0b013e3181ea9386
21. Tedesko M., Garelli V., Bellei B., Sperduti I., Chichierchia G., Latini A., Foddai M. L., Bertozzi E., Bonadies A., Pallara T., Romani C., Morrone A., Migliano E. Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP? Journal of Dermatological Treatment. 2020;6:1–5. DOI: 10.1080/09546634.2020.1854650
22. Eshtiaghi P., Sadownik L.A. Fact or Fiction? Adipose-Derived Stem Cells and Platelet-Rich Plasma for the Treatment of Vulvar Lichen Sclerosus. Journal of Lower Genital Tract Disease. 2019;23(1):65–70. DOI: 10.1097/lgt.0000000000000440
23. Villalpando B.K., Wyles S.P., Schaefer L.A., Bodiford K.J., Bruce A.J. Platelet-rich plasma for the treatment of lichen sclerosus. Plastic and Aesthetic Research. 2021;8:1–14. DOI: 10.20517/2347-9264.2021.86
24. Goldstein A.T., Mitchell L., Govind V., Heller D. A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus. Journal of the American Academy of Dermatology. 2019;80(6):1788–1789. DOI: 10.1016/j.jaad.2018.12.060
25. Orazov M. Platelet autoplasm in the treatment of vulgar pathology in perimenopausal women. Jesteticheskaja medicina. 2015;3:413–421. (In Russian).
26. Behnia-Willison F., Pour N.R., Mohamadi B., Willison N., Rock M., Holten I.W., O’Shea R., Miller J. Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen Sclerosus. Plastic and Reconstructive Surgery Global Open. 2016;4(11):11–24. DOI: 10.1097/GOX.0000000000001124
27. Goldstein A.T., King M., Runels C., Gloth M., Pfau R. Intradermal injection of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus. Journal of the American Academy of Dermatology. 2017;76(1):158–160. DOI: 10.1016/j.jaad.2016.07.037
28. Tedesko M., Pranteda G., Chichierchia G., Paolino G., Latini A., Orsini D., Cristaudo A., Foddai M.L., Migliano E., Morrone A. The use of PRP (platelet-rich plasma) in patients affected by genital lichen sclerosus: clinical analysis and results. Journal of the European Academy of Dermatology and Venereology: JEADV. 2019;33(2):58–59. DOI: 10.1111/jdv.15190
29. Novarrete J., Echarte L., Sujanov A. Platelet-rich plasma for male genital lichen sclerosus resistant to conventional therapy: First prospective study. Dermatologic Therapy. 2020;33(6):1–5. DOI: 10.1111/dth.14032
Review
For citations:
Parygina O.V., Oganesyan M.V., Shin N.V., Smirnova I.O. Platelet-rich plasma in the treatment of scleroatrophic lichen of the genitals. Clinical Medicine (Russian Journal). 2022;100(11-12):540-545. (In Russ.) https://doi.org/10.30629/0023-2149-2022-100-11-12-540-545
Views:
1150
Email this article 